Schizophrenia Research
Volume 112, Issue 1 , Pages 72-79 , July 2009

BDNF is not associated with schizophrenia: Data from a Japanese population study and meta-analysis

  • Kunihiro Kawashima

      Affiliations

    • Department of Psychiatry, Fujita Health University School of Medicine, Toyoake, Aichi 470-1192, Japan
    • CREST, Japan Science and Technology Agency, Saitama 332-0012, Japan
    • ,
  • Masashi Ikeda

      Affiliations

    • Department of Psychiatry, Fujita Health University School of Medicine, Toyoake, Aichi 470-1192, Japan
    • Department of Psychological Medicine, School of Medicine, Cardiff University, Heath Park, Cardiff, CF14 4XN, United Kingdom
    • ,
  • Taro Kishi

      Affiliations

    • Department of Psychiatry, Fujita Health University School of Medicine, Toyoake, Aichi 470-1192, Japan
    • CREST, Japan Science and Technology Agency, Saitama 332-0012, Japan
    • ,
  • Tsuyoshi Kitajima

      Affiliations

    • Department of Psychiatry, Fujita Health University School of Medicine, Toyoake, Aichi 470-1192, Japan
    • CREST, Japan Science and Technology Agency, Saitama 332-0012, Japan
    • ,
  • Yoshio Yamanouchi

      Affiliations

    • Department of Psychiatry, Fujita Health University School of Medicine, Toyoake, Aichi 470-1192, Japan
    • CREST, Japan Science and Technology Agency, Saitama 332-0012, Japan
    • ,
  • Yoko Kinoshita

      Affiliations

    • Department of Psychiatry, Fujita Health University School of Medicine, Toyoake, Aichi 470-1192, Japan
    • CREST, Japan Science and Technology Agency, Saitama 332-0012, Japan
    • ,
  • Tomo Okochi

      Affiliations

    • Department of Psychiatry, Fujita Health University School of Medicine, Toyoake, Aichi 470-1192, Japan
    • CREST, Japan Science and Technology Agency, Saitama 332-0012, Japan
    • ,
  • Branko Aleksic

      Affiliations

    • Department of Psychiatry, Nagoya University Graduate School of Medicine, Nagoya 466-8850, Japan
    • ,
  • Makoto Tomita

      Affiliations

    • Risk Analysis Research Center, The Institute of Statistical Mathematics, Tokyo, 106-8569, Japan
    • ,
  • Takeya Okada

      Affiliations

    • Department of Mental Disorder Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, 4-1-1, Ogawahigashi, Kodaira, Tokyo, 187-8502, Japan
    • ,
  • Hiroshi Kunugi

      Affiliations

    • Department of Mental Disorder Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, 4-1-1, Ogawahigashi, Kodaira, Tokyo, 187-8502, Japan
    • ,
  • Toshiya Inada

      Affiliations

    • Seiwa Hospital, Institute of Neuropsychiatry, Tokyo, 162-0851, Japan
    • ,
  • Norio Ozaki

      Affiliations

    • CREST, Japan Science and Technology Agency, Saitama 332-0012, Japan
    • Department of Psychiatry, Nagoya University Graduate School of Medicine, Nagoya 466-8850, Japan
    • ,
  • Nakao Iwata

      Affiliations

    • Department of Psychiatry, Fujita Health University School of Medicine, Toyoake, Aichi 470-1192, Japan
    • CREST, Japan Science and Technology Agency, Saitama 332-0012, Japan
    • Corresponding Author InformationCorresponding author. Department of Psychiatry, Fujita Health University School of Medicine, Toyoake, Aichi 470-1192, Japan. Tel.: +81 562 93 9250; fax: +81 562 93 1831.

Received 28 October 2008 ,Revised 21 March 2009 ,Accepted 28 March 2009.

References 

  1. Angelucci F, Brene S, Mathe AA. BDNF in schizophrenia, depression and corresponding animal models. Mol. Psychiatry. 2005;10:345–352
  2. Anttila S, Illi A, Kampman O, Mattila KM, Lehtimaki T, Leinonen E. Lack of association between two polymorphisms of brain-derived neurotrophic factor and response to typical neuroleptics. J. Neural Transm. 2005;112:885–890
  3. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21:263–265
  4. Chen QY, Chen Q, Feng GY, Wan CL, Lindpaintner K, Wang LJ, et al. Association between the brain-derived neurotrophic factor (BDNF) gene and schizophrenia in the Chinese population. Neurosci. Lett. 2006;397:285–290
  5. de Bakker PI, Yelensky R, Pe'er I, Gabriel SB, Daly MJ, Altshuler D. Efficiency and power in genetic association studies. Nat. Genet. 2005;37:1217–1223
  6. de Krom M, Bakker SC, Hendriks J, van Elburg A, Hoogendoorn M, Verduijn W, et al. Polymorphisms in the brain-derived neurotrophic factor gene are not associated with either anorexia nervosa or schizophrenia in Dutch patients. Psychiatr. Genet. 2005;15:81
  7. Donohoe G, Morris DW, Robertson IH, Clarke S, McGhee KA, Schwaiger S, et al. Variance in facial recognition performance associated with BDNF in schizophrenia. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2007;144B:578–579
  8. Dudbridge F. Pedigree disequilibrium tests for multilocus haplotypes. Genet. Epidemiol. 2003;25:115–121
  9. Durany N, Michel T, Zochling R, Boissl KW, Cruz-Sanchez FF, Riederer P, et al. Brain-derived neurotrophic factor and neurotrophin 3 in schizophrenic psychoses. Schizophr. Res. 2001;52:79–86
  10. Egan MF, Kojima M, Callicott JH, Goldberg TE, Kolachana BS, Bertolino A, et al. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell. 2003;112:257–269
  11. Galderisi S, Maj M, Kirkpatrick B, Piccardi P, Mucci A, Invernizzi G, et al. COMT Val(158)Met and BDNF C(270)T polymorphisms in schizophrenia: a case-control study. Schizophr. Res. 2005;73:27–30
  12. Han DH, Park DB, Choi TY, Joo SY, Lee MK, Park BR, et al. Effects of brain-derived neurotrophic factor-catecholamine-O-methyltransferase gene interaction on schizophrenic symptoms. Neuroreport. 2008;19:1155–1158
  13. Hong CJ, Yu YW, Lin CH, Tsai SJ. An association study of a brain-derived neurotrophic factor Val66Met polymorphism and clozapine response of schizophrenic patients. Neurosci. Lett. 2003;349:206–208
  14. Ikeda M, Iwata N, Suzuki T, Kitajima T, Yamanouchi Y, Kinoshita Y, et al. Association analysis of chromosome 5 GABAA receptor cluster in Japanese schizophrenia patients. Biol. Psychiatry. 2005;58:440–445
  15. Ingles SA, Haile RW, Henderson BE, Kolonel LN, Nakaichi G, Shi CY, et al. Strength of linkage disequilibrium between two vitamin D receptor markers in five ethnic groups: implications for association studies. Cancer Epidemiol. Biomarkers Prev. 1997;6:93–98
  16. Iritani S, Niizato K, Nawa H, Ikeda K, Emson PC. Immunohistochemical study of brain-derived neurotrophic factor and its receptor, TrkB, in the hippocampal formation of schizophrenic brains. Prog. Neuro-Psychopharmacol. Biol. Psychiatry. 2003;27:801–807
  17. Jonsson EG, Edman-Ahlbom B, Sillen A, Gunnar A, Kulle B, Frigessi A, et al. Brain-derived neurotrophic factor gene (BDNF) variants and schizophrenia: an association study. Prog. Neuro-psychopharmacol. Biol. Psychiatry. 2006;30:924–933
  18. Kamatani N, Sekine A, Kitamoto T, Iida A, Saito S, Kogame A, et al. Large-scale single-nucleotide polymorphism (SNP) and haplotype analyses, using dense SNP Maps, of 199 drug-related genes in 752 subjects: the analysis of the association between uncommon SNPs within haplotype blocks and the haplotypes constructed with haplotype-tagging SNPs. Am. J. Hum. Genet. 2004;75:190–203
  19. Kanazawa T, Glatt SJ, Kia-Keating B, Yoneda H, Tsuang MT. Meta-analysis reveals no association of the Val66Met polymorphism of brain-derived neurotrophic factor with either schizophrenia or bipolar disorder. Psychiatr. Genet. 2007;17:165–170
  20. Nanko S, Kunugi H, Hirasawa H, Kato N, Nabika T, Kobayashi S. Brain-derived neurotrophic factor gene and schizophrenia: polymorphism screening and association analysis. Schizophr. Res. 2003;62:281–283
  21. Naoe Y, Shinkai T, Hori H, Fukunaka Y, Utsunomiya K, Sakata S, et al. No association between the brain-derived neurotrophic factor (BDNF) Val66Met polymorphism and schizophrenia in Asian populations: evidence from a case-control study and meta-analysis. Neurosci. Lett. 2007;415:108–112
  22. Neves-Pereira M, Cheung JK, Pasdar A, Zhang F, Breen G, Yates P, et al. BDNF gene is a risk factor for schizophrenia in a Scottish population. Mol. Psychiatry. 2005;10:208–212
  23. Numata S, Ueno S, Iga J, Yamauchi K, Hongwei S, Ohta K, et al. Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism in schizophrenia is associated with age at onset and symptoms. Neurosci. Lett. 2006;401:1–5
  24. Okada T, Hashimoto R, Numakawa T, Iijima Y, Kosuga A, Tatsumi M, et al. A complex polymorphic region in the brain-derived neurotrophic factor (BDNF) gene confers susceptibility to bipolar disorder and affects transcriptional activity. Mol. Psychiatry. 2006;11:695–703
  25. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 2007;81:559–575
  26. Qian L, Zhao J, Shi Y, Zhao X, Feng G, Xu F, et al. Brain-derived neurotrophic factor and risk of schizophrenia: an association study and meta-analysis. Biochem. Biophys. Res. Commun. 2007;353:738–743
  27. Sand PG. Comments on the paper by D. Li and L. He: Meta-analysis shows association between the tryptophan hydroxylase (TPH) gene and schizophrenia. Hum Genet. 2007 Nov;122(3-4):409-11. 2007;
  28. Schumacher J, Jamra RA, Becker T, Ohlraun S, Klopp N, Binder EB, et al. Evidence for a relationship between genetic variants at the brain-derived neurotrophic factor (BDNF) locus and major depression. Biol. Psychiatry. 2005;58:307–314
  29. Skibinska M, Hauser J, Czerski PM, Leszczynska-Rodziewicz A, Kosmowska M, Kapelski P, et al. Association analysis of brain-derived neurotrophic factor (BDNF) gene Val66Met polymorphism in schizophrenia and bipolar affective disorder. World J. Biol. Psychiatry. 2004;5:215–220
  30. Stephens M, Donnelly P. A comparison of Bayesian methods for haplotype reconstruction from population genotype data. Am. J. Hum. Genet. 2003;73:1162–1169
  31. Suarez BK, Duan J, Sanders AR, Hinrichs AL, Jin CH, Hou C, et al Genomewide linkage scan of 409 European-ancestry and African American families with schizophrenia: suggestive evidence of linkage at 8p23.3–p21.2 and 11p13.1–q14.1 in the combined sample. Am. J. Hum. Genet. 2006;78:315–333
  32. Szczepankiewicz A, Skibinska M, Czerski PM, Kapelski P, Leszczynska-Rodziewicz A, Slopien A, et al. No association of the brain-derived neurotrophic factor (BDNF) gene C-270T polymorphism with schizophrenia. Schizophr. Res. 2005;76:187–193
  33. Szekeres G, Juhasz A, Rimanoczy A, Keri S, Janka Z. The C270T polymorphism of the brain-derived neurotrophic factor gene is associated with schizophrenia. Schizophr. Res. 2003;65:15–18
  34. Takahashi T, Suzuki M, Tsunoda M, Kawamura Y, Takahashi N, Tsuneki H, et al. Association between the brain-derived neurotrophic factor Val66Met polymorphism and brain morphology in a Japanese sample of schizophrenia and healthy comparisons. Neurosci. Lett. 2008;435:34–39
  35. Tan YL, Zhou DF, Cao LY, Zou YZ, Wu GY, Zhang XY. Effect of the BDNF Val66Met genotype on episodic memory in schizophrenia. Schizophr. Res. 2005;77:355–356
  36. Tochigi M, Otowa T, Suga M, Rogers M, Minato T, Yamasue H, et al. No evidence for an association between the BDNF Val66Met polymorphism and schizophrenia or personality traits. Schizophr. Res. 2006;87:45–47
  37. Toyooka K, Asama K, Watanabe Y, Muratake T, Takahashi M, Someya T, et al. Decreased levels of brain-derived neurotrophic factor in serum of chronic schizophrenic patients. Psychiatry Res. 2002;110:249–257
  38. Verhagen M, van der Meij A, van Deurzen PA, Janzing JG, Arias-Vasquez A, Buitelaar JK, et al. Meta-analysis of the BDNF Val66Met polymorphism in major depressive disorder: effects of gender and ethnicity. Mol Psychiatry. 2008 Oct 14. 2008;[Epub ahead of print]
  39. Watanabe Y, Muratake T, Kaneko N, Nunokawa A, Someya T. No association between the brain-derived neurotrophic factor gene and schizophrenia in a Japanese population. Schizophr. Res. 2006;84:29–35
  40. Watanabe Y, Nunokawa A, Kaneko N, Someya T. Meta-analysis of case-control association studies between the C270T polymorphism of the brain-derived neurotrophic factor gene and schizophrenia. Schizophr Res. 2007 Sep;95(1-3):250-2. 2007;
  41. Xu MQ, St Clair D, Ott J, Feng GY, He L. Brain-derived neurotrophic factor gene C-270T and Val66Met functional polymorphisms and risk of schizophrenia: a moderate-scale population-based study and meta-analysis. Schizophr. Res. 2007;91:6–13
  42. Zhang H, Ozbay F, Lappalainen J, Kranzler HR, van Dyck CH, Charney DS, et al. Brain derived neurotrophic factor (BDNF) gene variants and Alzheimer's disease, affective disorders, posttraumatic stress disorder, schizophrenia, and substance dependence. Am. J. Med. Genet., B Neuropsychiatr. Genet. 2006;141:387–393
  43. Zintzaras E. Brain-derived neurotrophic factor gene polymorphisms and schizophrenia: a meta-analysis. Psychiatr. Genet. 2007;17:69–75
  44. Zorner B, Wolfer DP, Brandis D, Kretz O, Zacher C, Madani R, et al. Forebrain-specific trkB-receptor knockout mice: behaviorally more hyperactive than “depressive”. Biol. Psychiatry. 2003;54:972–982

PII: S0920-9964(09)00137-6

doi: 10.1016/j.schres.2009.03.040

Schizophrenia Research
Volume 112, Issue 1 , Pages 72-79 , July 2009

Article Tools

* Image Usage & Resolution